FAZIOLI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 4.928
EU - Europa 3.146
AS - Asia 1.762
SA - Sud America 356
AF - Africa 135
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.345
Nazione #
US - Stati Uniti d'America 4.846
RU - Federazione Russa 1.574
SG - Singapore 531
VN - Vietnam 425
IT - Italia 336
BR - Brasile 289
CN - Cina 272
UA - Ucraina 266
HK - Hong Kong 200
SE - Svezia 195
DE - Germania 176
IE - Irlanda 148
DK - Danimarca 101
FR - Francia 101
TR - Turchia 94
CI - Costa d'Avorio 89
GB - Regno Unito 81
FI - Finlandia 79
KR - Corea 55
CA - Canada 50
IN - India 33
AR - Argentina 29
BD - Bangladesh 28
MX - Messico 26
JP - Giappone 20
BE - Belgio 19
NL - Olanda 19
ZA - Sudafrica 15
IQ - Iraq 13
CO - Colombia 12
PL - Polonia 12
ID - Indonesia 11
AT - Austria 10
PH - Filippine 10
SA - Arabia Saudita 10
CL - Cile 8
MA - Marocco 8
NZ - Nuova Zelanda 8
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
EC - Ecuador 6
UZ - Uzbekistan 6
ES - Italia 5
JO - Giordania 5
PK - Pakistan 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AU - Australia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
OM - Oman 4
TH - Thailandia 4
AZ - Azerbaigian 3
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
PY - Paraguay 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
HR - Croazia 2
NG - Nigeria 2
NP - Nepal 2
PS - Palestinian Territory 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
PA - Panama 1
PE - Perù 1
SN - Senegal 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.345
Città #
Dallas 1.476
Ashburn 433
Chandler 351
Singapore 321
Des Moines 289
Jacksonville 263
Hong Kong 188
Boardman 159
Fairfield 156
Ho Chi Minh City 153
Dublin 148
New York 124
Ann Arbor 119
San Jose 114
Hanoi 93
Abidjan 89
Wilmington 88
Houston 86
Woodbridge 84
Beijing 75
The Dalles 69
Los Angeles 63
Seattle 60
Lawrence 58
Princeton 58
San Mateo 57
Cambridge 53
Lauterbourg 53
Moscow 49
Hefei 44
Milan 38
Centro 33
São Paulo 32
Marche 31
Ottawa 28
Munich 27
Turin 24
Helsinki 21
Buffalo 20
Redmond 20
Brussels 19
Da Nang 19
Orem 17
Rome 17
San Diego 17
Haiphong 16
Ancona 15
Tokyo 15
Chicago 14
Poplar 13
London 12
Montreal 11
Washington 11
Boston 10
Guangzhou 10
Tampa 10
Warsaw 10
Chennai 9
Columbus 9
Mexico City 9
Nuremberg 9
Santa Clara 9
Brasília 8
Dhaka 8
Manchester 8
Salt Lake City 8
Turku 8
Belo Horizonte 7
Brooklyn 7
Curitiba 7
Elk Grove Village 7
Frankfurt am Main 7
Norwalk 7
Porto Alegre 7
Wuhan 7
Atlanta 6
Biên Hòa 6
Denver 6
Hải Dương 6
Jakarta 6
Johannesburg 6
Padova 6
Ribeirão Preto 6
San Francisco 6
Shanghai 6
Tashkent 6
Amman 5
Amsterdam 5
Bogotá 5
Can Tho 5
Quận Ba 5
Rio de Janeiro 5
Seoul 5
Tolentino 5
Vienna 5
Wellington 5
Ankara 4
Auburn Hills 4
Belgrade 4
Bắc Ninh 4
Totale 6.156
Nome #
110 SERUM LEVELS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA 2.223
Circulating inflamma-miRs in aging and age-related diseases. 804
Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer's Disease 226
Analysis of M1 and M2 tumor associated macrophages in tongue squamous cell carcinomas. 208
Cytotoxicity in vitro of two non-commercial samples of chrysotile and fibrous erionite 200
In Vitro H2O2 Stress And Patterns Of Mitochondrial Damage In The Nctc 2544 Continuous Cell Line 195
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 193
Activation of transcription factors STAT1 and STAT5 in the mouse median eminence after systemic ciliary neurotrophic factor administration 192
Cytotoxic and genotoxic potential of asbestos fibers from environmental outcrops 188
Fisiopatologia degli organi emopoietici e del sangue 177
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 166
Biosynthesis and apical localization of the urokinase receptor in polarized MDCK epithelial cells. 153
A ligand-inducible anaplastic lymphoma kinase chimera is endocytosis impaired 149
Prognostic Relevance of Macrophage Phenotypes in High-grade Oral Tongue Squamous Cell Carcinomas 148
Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase. 146
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes. 144
Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase 143
Absence of somatic mutations in natriuretic peptide receptor type A gene in human aldosterone-secreting adenomas 142
Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. 139
Plasma levels of interleukin-38 in healthy aging and in type 2 diabetes 139
The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. 135
Asbestos induced toxicity: in vitro different effects of different fibres. 135
The Experimental Pathology at Ancona: 50 Years of Exciting and Pioneering Research on Human Pathology 133
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia. 131
A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. 131
A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. 127
Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. 126
The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction. 125
77 Soluble urokinase receptor expression in urine is a prognostic marker in patients with transitional cell carcinoma of the bladder 123
erbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling. 120
Analisys of Y-linked microdeletions in idiopathic oligo- and azoospermic patients 119
Cancerogenesi chimica e fisica 118
Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. 117
Sex/gender-related differences in inflammaging 115
eps15, a novel tyrosine kinase substrate, exhibits transforming activity. 113
A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells 113
Removal of domain D2 or D3 of the human urokinase receptor does not affect ligand affinity. 112
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 112
miR-132–3p is down-regulated in plasma and CD171+ extracellular vesicles isolated from patients with mild Alzheimer’s disease 110
Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. 110
Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study. 105
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 105
Polynucleotide and substrate for the epidermal growth factor receptor kinase (EPS8) 103
Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent. 101
Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia. 100
DNA encoding human and murine EPS15, a substrate for the epidermal growth factor receptor 99
The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing. 99
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 99
Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre parameters to the key characteristics of carcinogens: a comprehensive model inspiring asbestos-induced cancer prevention strategies 95
Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer 93
uPAR mimicking peptides 91
SERUM SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS A USEFUL MARKER OF PROSTATE CANCER 89
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 88
In Vitro H202 stress and patterns of mitochondrial damage in the NCTC 2544 Continuous cell line- a morphological and morphometric study. 87
Serum soluble urokinase-type plasminigen activator receptor (Supar) is a useful marker of prostate cancer 84
Survivin detection in saliva samples from patient with oral squamous cell carcinoma 83
The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency. 72
Purification of tyrosine phosphorylated proteins by immunoaffinity chromatography and direct cloning of their cDNAs from bacterial expression libraries 72
Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells 69
Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy? 68
PPARγ expression in normal human placenta, hydatidiform mole and choriocarcinoma 62
The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. 59
Totale 10.423
Categoria #
all - tutte 32.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021193 0 0 0 0 0 0 0 0 0 59 87 47
2021/2022447 24 94 2 21 10 29 18 36 33 40 52 88
2022/20231.179 77 109 80 98 83 357 2 63 217 6 61 26
2023/2024585 88 15 35 98 92 123 7 14 2 28 15 68
2024/20251.134 163 86 68 8 42 24 120 58 224 118 102 121
2025/20265.325 248 559 1.124 315 271 231 620 259 1.525 173 0 0
Totale 10.423